Rivaroxaban 2.5 mg BID and Aspirin for Intermittent Claudication in PAD Patients

NCT04853719 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Peripheral Artery Disease
Intermittent Claudication

Interventions

DRUG: Rivaroxaban 2.5 Mg Oral Tablet

Sponsor

Science Valley Research Institute

Collaborators

[object Object]